Anti-platelet effects of Rosiglitazone: A direct consequence of PLATELET PPAR-γ ACTIVATION Read more about Anti-platelet effects of Rosiglitazone: A direct consequence of PLATELET PPAR-γ ACTIVATION
HbA1c is not a sufficiently reliable marker of glycaemic control in diabetes care Read more about HbA1c is not a sufficiently reliable marker of glycaemic control in diabetes care
Diabetes & Anti-psychotic drugs: Genuine Concern or Industry Hype? Read more about Diabetes & Anti-psychotic drugs: Genuine Concern or Industry Hype?
Gestational Diabetes Mellitus; National Audit Read more about Gestational Diabetes Mellitus; National Audit
Impact of Oestrogen Therapy on Diabetes and Vascular Risk Read more about Impact of Oestrogen Therapy on Diabetes and Vascular Risk
Roles and risks of insulin pump therapy in Type 1 diabetes Read more about Roles and risks of insulin pump therapy in Type 1 diabetes
Role of small fibre neuropathy and microvascular hyperaemia in wound healing in diabetes Read more about Role of small fibre neuropathy and microvascular hyperaemia in wound healing in diabetes
Androgen Replacement Therapy in the Management of Men with Type 2 Diabetes Read more about Androgen Replacement Therapy in the Management of Men with Type 2 Diabetes
The contribution of specialist services to integrated diabetes care Read more about The contribution of specialist services to integrated diabetes care
